Home: Health & Wellbeing: Page 30 News Releases: Pages: [<<] ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... [>>]

  • Carglumic Acid Market Size, Share, Trends and Future Growth Predictions and Forecast 2017 – 2026

    MRRSE Research has compiled a new comprehensive report on the global Carglumic Acid Market for the forecast period 2017 to 2026. The report offers insightful forecasts on global carglumic acid market, and has examined the market in detail, providing key market dynamics inclusively. In addition to the provision of intelligence on latest trends, restraining factors, and fostering factors affecting the market expansion, the report includes analysis on data pertaining to multiple market parameters.


     (Filed: Wed Jul 31 2019)

  • Diabetes Drugs Market Analysis Covering Size, Share, Growth, Trends and Upcoming Opportunities 2017


    This report on the Diabetes Drugs Market analyzes the current and future scenario of the global market. Rise in private and public funding for diabetes drugs, rising prevalence of diabetes, and favorable regulatory scenario for new drug launch are boosting the growth of the Diabetes drugs market. Increasing geriatric population across the world and rising incidence and prevalence of diabetes such as Type 2 diabetes and Type 1 diabetes are some of the factors expected to drive the growth of Diabetes drugs market during the forecast period.


     (Filed: Wed Jul 31 2019)

  • Dry Eye Disease Market Size, Share, Trends and Future Growth Predictions and Forecast, 2017 – 2025

    Dry eye is an ocular disease caused due to insufficiency or lack of tears in eye. Tears made up of three layers viz. lipids, mucin and aqueous keep eye moist and lubricated. Lack of tears lead to redness, burning, sensing and pain in eye. Dry eye disease also known as Keratoconjuctivitis Sicca is a common phenomenon, which is estimated to have prevalence of 8% to 34% across the globe. Dry eye disease is categorized into evaporative dry eye disease and aqueous deficiency dry eye disease.


    (Filed: Wed Jul 31 2019)

  • Erythropoietin Drugs Market Size, Share, Trends and Future Growth Predictions and Forecast 2017 – 20

    Erythropoietin is a hormone which produce inside the body from kidney. EPO helps in the development of RBC inside the body and high number of RBC increases the level of hemoglobin in the blood which transport the oxygen in every part of the body. The market for these erythropoietin drugs is anticipated to grow significantly in the forecast period, owing to the rising prevalence of chronic diseases, focus of government and non-government organizations on creating awareness, research and development grants, and fee waivers and tax credits offered, among others.


    (Filed: Wed Jul 31 2019)

  • Focal Segmental Glomerulosclerosis (FSGS) Market Size, Share, Trends and Future Growth Predictions &

    This report on focal segmental glomerulosclerosis (FSGS) market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacturing and commercialization of diagnostic and therapeutic products for focal segmental glomerulosclerosis (FSGS) as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study.


    (Filed: Wed Jul 31 2019)

  • Inflammatory Bowel Disease (IBD) Treatment Market Size, Share, Trends and Future Growth Predictions


    Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes the inflammation sores in the inner lining of colon and rectum. The Crohn’s disease affects any part of gastrointestinal tract and unlike ulcerative colitis, it affects all the layers of gastrointestinal walls.


    (Filed: Wed Jul 31 2019)

  • Influenza Medication Market Analysis Showcases Growth Trends and Opportunity Forecasted Until 2025

    This report on Influenza Medication Market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of Influenza Medication Market products such as Zanamivir, Oseltamivir, Peramivir, and others as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study.


    (Filed: Wed Jul 31 2019)

  • Liquid Biopsy Market Size, Share, Trends and Future Growth Predictions and Forecast 2018 – 2026

    This report on the global Liquid Biopsy Market analyzes the current and future prospects of the market. The report comprises a comprehensive executive summary, including a market snapshot that provides overall information of various segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases.


    (Filed: Wed Jul 31 2019)

  • Myasthenia Gravis Market Size, Share, Trends and Future Growth Predictions and Forecast 2017 – 2025

    Myasthenia gravis is a chronic, debilitating and neuromuscular autoimmune disease that can take place at any time of life but most often starts for men after the age of 55 and women around the age of 40. Most of patients with generalized myasthenia gravis possible and can be managed with present therapies for myasthenia gravis, 10-15% of patients fail to respond tolerably to or cannot bear multiple therapies for myasthenia gravis and continue to suffer deep muscle weakness, and severe disease symptoms that limits function.


    (Filed: Wed Jul 31 2019)

  • Myasthenia Gravis Market Size, Share, Trends and Future Growth Predictions and Forecast 2017 – 2025

    Myasthenia gravis is a chronic, debilitating and neuromuscular autoimmune disease that can take place at any time of life but most often starts for men after the age of 55 and women around the age of 40. Most of patients with generalized myasthenia gravis possible and can be managed with present therapies for myasthenia gravis, 10-15% of patients fail to respond tolerably to or cannot bear multiple therapies for myasthenia gravis and continue to suffer deep muscle weakness, and severe disease symptoms that limits function.


    (Filed: Wed Jul 31 2019)
Pages: [<<] ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... [>>]